ArticleThe oncologist2025

Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy.

Wambui Gathirua-Mwangi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.